BACKGROUND AND OBJECTIVES: Time-resolved autofluorescence spectroscopy has been used for effectively distinguishing normal tissues from precancers and cancers in various organs. The aim of this study was to find out the possibility of using time-resolved autofluorescence spectroscopy to differentiate normal oral mucosa (NOM) from oral premalignant lesions including verrucous hyperplasia (VH), epithelial hyperplasia (EH), and epithelial dysplasia (ED). STUDY DESIGN/ MATERIALS AND METHODS: Time-resolved autofluorescence spectra at 633 nm under 410-nm excitation were recorded for 15 VH, 9 EH, 14 ED, and 38 NOM samples. The two-component lifetimes of the obtained curves were calculated, and a Fisher's discriminant analysis (FDA) was employed for distinguishing these tissue samples. RESULTS: After two-component lifetimes for all samples being calculated, a two-dimensional scatter plot was developed, in which 76 oral tissue samples were separated into three groups by FDA. With a leave-one-out method, the FDA algorithm gave an accuracy rate of 93% for ED, of 75% for VH and EH, and of 100% for NOM samples. In addition, all oral premalignant lesions (including VH, EH, and ED) could be distinguished from NOM samples by this FDA algorithm. CONCLUSIONS: We conclude that time-resolved autofluorescence spectroscopy at 633 nm under 410-nm excitation, based on two-component lifetime calculation and FDA, is a very sensitive technique for in vivo diagnosis of oral premalignant lesions. . (c) 2005 Wiley-Liss, Inc
BACKGROUND AND OBJECTIVES: Time-resolved autofluorescence spectroscopy has been used for effectively distinguishing normal tissues from precancers and cancers in various organs. The aim of this study was to find out the possibility of using time-resolved autofluorescence spectroscopy to differentiate normal oral mucosa (NOM) from oral premalignant lesions including verrucous hyperplasia (VH), epithelial hyperplasia (EH), and epithelial dysplasia (ED). STUDY DESIGN/ MATERIALS AND METHODS: Time-resolved autofluorescence spectra at 633 nm under 410-nm excitation were recorded for 15 VH, 9 EH, 14 ED, and 38 NOM samples. The two-component lifetimes of the obtained curves were calculated, and a Fisher's discriminant analysis (FDA) was employed for distinguishing these tissue samples. RESULTS: After two-component lifetimes for all samples being calculated, a two-dimensional scatter plot was developed, in which 76 oral tissue samples were separated into three groups by FDA. With a leave-one-out method, the FDA algorithm gave an accuracy rate of 93% for ED, of 75% for VH and EH, and of 100% for NOM samples. In addition, all oral premalignant lesions (including VH, EH, and ED) could be distinguished from NOM samples by this FDA algorithm. CONCLUSIONS: We conclude that time-resolved autofluorescence spectroscopy at 633 nm under 410-nm excitation, based on two-component lifetime calculation and FDA, is a very sensitive technique for in vivo diagnosis of oral premalignant lesions. . (c) 2005 Wiley-Liss, Inc
Authors: Shuna Cheng; Rodrigo M Cuenca; Boang Liu; Bilal H Malik; Joey M Jabbour; Kristen C Maitland; John Wright; Yi-Shing Lisa Cheng; Javier A Jo Journal: Biomed Opt Express Date: 2014-02-26 Impact factor: 3.732
Authors: Bilal H Malik; Joey M Jabbour; Shuna Cheng; Rodrigo Cuenca; Yi-Shing Lisa Cheng; John M Wright; Javier A Jo; Kristen C Maitland Journal: Oral Surg Oral Med Oral Pathol Oral Radiol Date: 2015-10-26
Authors: D Gregory Farwell; Jeremy D Meier; Jesung Park; Yang Sun; Heather Coffman; Brian Poirier; Jennifer Phipps; Steve Tinling; Danny J Enepekides; Laura Marcu Journal: Arch Otolaryngol Head Neck Surg Date: 2010-02
Authors: Jeremy D Meier; Hongtao Xie; Yang Sun; Yinghua Sun; Nisa Hatami; Brian Poirier; Laura Marcu; D Gregory Farwell Journal: Otolaryngol Head Neck Surg Date: 2010-06 Impact factor: 3.497
Authors: Yang Sun; Hongtao Xie; Jing Liu; Matthew Lam; Abhijit J Chaudhari; Feifei Zhou; Julien Bec; Diego R Yankelevich; Allison Dobbie; Steven L Tinling; Regina F Gandour-Edwards; Wayne L Monsky; D Gregory Farwell; Laura Marcu Journal: J Biomed Opt Date: 2012-11 Impact factor: 3.170